ATLL patients also often express receptor activator of NF-kB ligand (RANKL), which cooperates with macrophage colony-stimulating-factor to stimulate haematopoietic precursors into osteoclasts. This evidence concerns the gene TNFSF11 and adult T-cell leukemia/lymphoma.